Yehia M. Elshazly

Cairo, C, Egypt

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Diabetic patients with chronic hepatitis C virus response compared to non diabetics when treated with directly acting antiviral therapy.

Diabetic patients with chronic hepatitis C virus response compared to non diabetics when treated with directly acting antiviral therapy.

Journal: Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology
Published: March 31, 2022

Seroprevalence of HBV/HCV coinfection among patients with HCV screened during the national campaign for HCV eradication in Egypt.

Seroprevalence of HBV/HCV coinfection among patients with HCV screened during the national campaign for HCV eradication in Egypt.

Journal: Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology
Published: November 14, 2021

Efficacy and safety of ombitasvir/paritaprevir/ritonavir-based therapy in HCV patients with chronic kidney disease.

Efficacy and safety of ombitasvir/paritaprevir/ritonavir-based therapy in HCV patients with chronic kidney disease.

Journal: Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology
Published: October 01, 2020

The outcome of re-treatment of relapsed hepatitis C virus infection in a resource-limited setting.

The outcome of re-treatment of relapsed hepatitis C virus infection in a resource-limited setting.

Journal: Virusdisease
Published: July 30, 2020

Simple predictors of nonresponse to direct-acting antivirals in chronic hepatitis C patients.

Simple predictors of nonresponse to direct-acting antivirals in chronic hepatitis C patients.

Journal: European journal of gastroenterology & hepatology
Published: December 03, 2019

Ritonavir-boosted paritaprevir, ombitasvir plus ribavirin could improve eGFR in patients with renal impairment and HCV: an Egyptian cohort.

Ritonavir-boosted paritaprevir, ombitasvir plus ribavirin could improve eGFR in patients with renal impairment and HCV: an Egyptian cohort.

Journal: Expert review of gastroenterology & hepatology
Published: February 23, 2019

Real-Life Efficacy of 5 Different Antiviral Regimens for Treatment of Chronic Hepatitis C With Normal Liver Enzymes.

Real-Life Efficacy of 5 Different Antiviral Regimens for Treatment of Chronic Hepatitis C With Normal Liver Enzymes.

Journal: American journal of therapeutics
Published: August 21, 2018

Spur-of-the-Moment Modification in National Treatment Policies Leads to a Surprising HCV Viral Suppression in All Treated Patients: Real-Life Egyptian Experience.

Spur-of-the-Moment Modification in National Treatment Policies Leads to a Surprising HCV Viral Suppression in All Treated Patients: Real-Life Egyptian Experience.

Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Published: January 23, 2018

National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care.

National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care.

Journal: Journal of viral hepatitis
Published: December 15, 2016

Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients.

Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: May 30, 2016
Showing 1-10 of 10

Last Updated: 09/26/2026